MTOR and Parkinson disease: RTP801 is both sufficient and necessary to mediate neuron death in in vitro and in vivo models of PD.19 This involves a sequential mechanism in which it first blocks mTOR activation and then, as a consequence, leads to the inactivation of the neuronal survival kinase Akt, which is also an mTOR substrate.20